![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Weller, Jonathan; Katzendobler, Sophie; Niedermeyer, Sebastian 
ORCID: https://orcid.org/0000-0003-2647-7256; Harter, Patrick N.; Herms, Jochen; Trumm, Christoph G. ORCID: https://orcid.org/0000-0002-1249-3338; Niyazi, Maximilian; Thon, Niklas; Tonn, Joerg-Christian und Stöcklein, Veit M.
(2023):
Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status.
In: Journal of Neuro-Oncology, Bd. 163, Nr. 2: S. 407-415
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-2647-7256; Harter, Patrick N.; Herms, Jochen; Trumm, Christoph G. ORCID: https://orcid.org/0000-0002-1249-3338; Niyazi, Maximilian; Thon, Niklas; Tonn, Joerg-Christian und Stöcklein, Veit M.
(2023):
Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status.
In: Journal of Neuro-Oncology, Bd. 163, Nr. 2: S. 407-415
[PDF, 1MB]
Karschnia, Philipp; Weller, Jonathan; Blobner, Jens; Stöcklein, Veit M.; Dorostkar, Mario M.; Rejeski, Kai; Forbrig, Robert; Niyazi, Maximilian; Baumgarten, Louisa von; Dietrich, Jorg; Tonn, Joerg-Christian und Thon, Niklas
(2021):
Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers.
In: Scientific reports, Bd. 11, Nr. 1, 20045
[PDF, 1MB]
Mastrella, Giorgia; Hou, Mengzhuo; Li, Min; Stöcklein, Veit M.; Zdouc, Nina; Vomar, Marie N. M.; Miletic, Hrvoje; Reinhard, Soeren; Herold-Mende, Christel C.; Kleber, Susanne; Eisenhut, Katharina; Gargiulo, Gaetano; Synowitz, Michael; Vescovi, Angelo L.; Harter, Patrick N.; Penninger, Josef M.; Wagner, Ernst; Mittelbronn, Michel; Bjerkvig, Rolf; Hambardzumyan, Dolores; Schueller, Ulrich; Tonn, Jörg-Christian; Radke, Josefine; Glass, Rainer und Kaelin, Roland E.
(2019):
Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma.
In: Cancer Research, Bd. 79, Nr. 9: S. 2298-2313